The Complete Guide to Viral Reactivation
Last Update: July 2026
Viral reactivation Long COVID is becoming one of the most important areas of Long COVID research. Scientists are increasingly investigating whether dormant viruses such as Epstein-Barr virus (EBV), herpes simplex virus (HSV), shingles (VZV) and HHV-6 can reactivate after COVID-19, potentially contributing to symptoms such as fatigue, brain fog, swollen lymph nodes and recurrent viral outbreaks.
Here is the explanation that holds together.
The viruses you are experiencing are not new. They moved in years ago and have been living rent free in your cells ever since. What COVID did was take away the landlord, temporarily. When your immune system becomes overwhelmed fighting SARS CoV 2, the surveillance that normally keeps latent viruses quietly dormant becomes unreliable. Viruses that have been doing nothing for years take the opportunity.
This is not unusual. It is not a coincidence. And the evidence for it is now substantial enough to take seriously rather than attribute to stress. Understanding viral reactivation in Long COVID helps explain why dormant infections can become active again and why symptoms often fluctuate over time.
Meet the herpesvirus family
Before getting into what happens in Long COVID specifically, it helps to understand just how thoroughly this virus family has colonised the human species.
There are eight human herpesviruses. By the time most people reach adulthood, they are carrying at least four of them.
EBV (Epstein Barr virus) causes glandular fever and then hides for life inside your B cells. Over 90 percent of adults carry it.
HSV 1 (herpes simplex type 1) causes cold sores and lives in nerve cells near the lips. The majority of adults carry this one too, often caught in childhood from a kiss from a relative, which is an undignified origin story but a very common one.
HSV 2 (herpes simplex type 2) causes genital herpes and lives in nerve cells in the sacral ganglia. Significantly less universal but still affecting a substantial proportion of the population.
VZV (varicella zoster virus) causes chickenpox on first infection and then retreats into dorsal root ganglia, where it can re emerge decades later as shingles. If you had chickenpox, you are carrying VZV.
CMV (cytomegalovirus) causes a mild illness in healthy people, often unnoticed, and then becomes latent. Over half of adults carry it.
HHV 6 (human herpesvirus 6) causes roseola in infants and then hides in monocytes, macrophages and salivary glands. More than 90 percent of adults are infected before the age of three, most without ever knowing.
All six of these, and the other two that are rarer, share the same fundamental strategy. Infect the host. Establish a latent state where the immune system cannot fully eliminate them. Wait indefinitely. Reactivate when immune surveillance weakens. Repeat.
COVID is an unusually effective weakener of that surveillance.
What the research shows
The signal here is not subtle. The original Pathogens study in 2021 found that 66.7 percent of Long COVID patients showed markers of EBV reactivation, compared with 10 percent of people who recovered from COVID without persistent symptoms, as documented in this original study linking EBV reactivation to Long COVID. A statistically significant difference of that magnitude, 66.7 versus 10, is not a coincidence effect.
Since then, at least five independent studies have replicated some version of this finding, with EBV reactivation showing up more frequently and with higher antibody levels in people with more severe Long COVID symptoms, as outlined in this Health Rising overview of EBV and fatigue in Long COVID research. The reactivation has been specifically linked to fatigue and cognitive symptoms rather than to gastrointestinal or cardiovascular Long COVID presentations, which provides an important mechanistic clue about what EBV specifically is contributing.
HHV 6 is increasingly part of the picture. A 2024 study in the Journal of Medical Virology found that Long COVID patients showed elevated immune responses to HHV 6 alongside autoimmune reactions against tight junction proteins and neuronal antigens, including myelin basic protein, as documented in this Journal of Medical Virology study on HHV 6 and autoimmunity in Long COVID. A separate study found that among 88 COVID patients, 72.3 percent tested positive for herpesvirus reactivation including EBV, HHV 6 and CMV, as outlined in this PMC review of viral persistence and herpesvirus reactivation in Long COVID.
The December 2025 ScienceDaily piece summarising new work from prominent microbiologists described this direction of research as one of the most important emerging frameworks for understanding Long COVID: hidden infections reactivating alongside or triggered by SARS CoV 2, creating a layered immune burden that the body cannot resolve cleanly, as covered in this ScienceDaily piece on viral suspects in Long COVID.
What it actually feels like: virus by virus
EBV reactivation
EBV is the one that most resembles “having glandular fever again, but quieter.” The fatigue is the deepest and most characteristic feature: not tired in the way that sleep would fix, but a systemic heaviness that does not lift. Swollen, tender lymph nodes, particularly in the neck and sometimes the armpits. A sore throat that comes and goes without ever quite resolving. Aching joints. Cognitive symptoms that feel heavier than usual, more sluggish, harder to shake. Low grade fever that fluctuates rather than spikes.
The crucial thing EBV reactivation often lacks is anything visible. No rash. No sore you can point to. Just the internal experience of feeling actively unwell in a way that is hard to describe to someone who has not been through it. This invisibility is one of the main reasons EBV reactivation goes unrecognised, and one of the main reasons people in Long COVID communities spend so long trying to explain a fatigue that seems to have no external cause.
HSV 1 reactivation (cold sores)
You know when you have this one. The prodrome, the tingling or burning that precedes the blister, is usually about twelve to twenty four hours before the lesion appears. Then the blister itself, typically at the lip border, lasting seven to ten days in a normal immune state, often longer when immunity is compromised. In Long COVID, cold sores appear more frequently and sometimes more severely than before. On the inside of the mouth, HSV can cause ulcers that are painful enough to make eating difficult, sometimes confused with aphthous ulcers but with a slightly different pattern, typically starting as small fluid filled blisters before breaking down.
The timing gives you information. Cold sores appearing immediately after a period of significant fatigue, overexertion or stress, are almost certainly post exertional reactivation. They are a visible signal that the immune system is under more strain than usual. Unpleasant but diagnostically useful.
HSV 2 reactivation
The same mechanism, different location. People who had infrequent outbreaks before COVID may find them more frequent and sometimes more prolonged afterwards. Prodrome symptoms, itching, burning, tingling in the genital or perianal region, can themselves be distressing and mimic other symptoms. During active outbreaks there can be systemic symptoms including fatigue and flu like feelings, which in the context of Long COVID can be difficult to separate from baseline symptoms.
VZV reactivation (shingles)
Shingles after COVID in someone under fifty is one of the cleaner signals that something real is happening to immune regulation. VZV has been dormant in your dorsal root ganglia since chickenpox, perhaps thirty years ago. It does not reactivate without reason.
Shingles typically begins with pain, burning, or itching along a dermatomal band, one side of the torso, face, or a limb, before any rash appears. This prodromal pain can last several days and is sometimes mistaken for something else entirely before the characteristic blistering rash appears, usually following the path of a single nerve. The pain can be intense and is sometimes described as burning, stabbing or electric. Post herpetic neuralgia, pain that persists after the rash has healed, can last months in some cases.
The rash blisters, crusts over and heals. The nerve pain is the problem that tends to linger. If you are experiencing shingles and have had Long COVID, please see a GP urgently: antiviral treatment is substantially more effective when started within the first 72 hours of rash appearance.
HHV 6 reactivation
Less immediately obvious than the others. HHV 6 reactivation symptoms include persistent fatigue, recurrent lymphadenopathy (that swollen lymph node feeling that does not seem to resolve), sore throat, low grade fever, and in some cases thyroid disruption. It does not produce a characteristic visible lesion in adults. Its involvement in Long COVID is harder to detect and harder to discuss with a GP, partly because routine HHV 6 testing is not standard in most healthcare settings and partly because the symptoms overlap so extensively with Long COVID itself.
The swollen lymph nodes
A specific word on this because it comes up constantly in Long COVID communities and causes significant anxiety: the lymph nodes that feel tender and swollen in the neck, under the arm, or in the groin that will not completely resolve.
Lymph nodes are immune organs. When the immune system is activated, lymph nodes enlarge as they process the response. In viral reactivation, particularly EBV and HHV 6, lymphadenopathy is a consistent feature. The nodes are typically soft, mobile, and tender rather than hard and fixed. They may be consistently present for weeks or months during periods of immune activation.
Persistent lymphadenopathy warrants clinical review, not because it is usually sinister in the context of Long COVID and known viral reactivation, but because a clinician should assess it, particularly if nodes are large, rapidly enlarging, hard, non tender, or accompanied by night sweats and significant weight loss, which are different flags requiring different investigation.
In the context of known EBV positivity or viral reactivation, tender cervical lymphadenopathy is entirely consistent with what the immune system is doing.
The blood test situation (because it will confuse you)
You will get blood test results that seem to say everything and nothing simultaneously. Here is how to read them.
IgG antibodies reflect past exposure. If you have ever had EBV, you will have positive EBV IgG for life. A positive EBV IgG tells you that you have had EBV. It does not tell you whether anything is currently active.
IgM antibodies can rise during recent or reactivated infection. A positive EBV IgM in someone with Long COVID symptoms suggests recent activity. It does not automatically mean a new primary infection.
EBV early antigen (EA D IgG) is the most specific marker for reactivation. This is the antibody that was elevated in the original Long COVID study. Elevated EA D alongside symptoms is the strongest blood test signal of active reactivation. This is the marker to specifically request if you are making a case to your GP.
HHV 6 IgG is widely positive in adults. HHV 6 serology is difficult to interpret, partly because almost everyone has been infected, partly because certain medications and immune conditions can produce confusing patterns, and partly because active reactivation is better detected through quantitative PCR of whole blood rather than antibody testing alone.
The practical conclusion: tell your clinician specifically what you are asking them to test for and why, rather than asking for a general viral screen. A targeted request for EBV reactivation markers (EA D IgG, VCA IgM) alongside your symptom history is more likely to produce useful information than a vague screen that returns everything positive because you are an adult who has had all of these viruses.
What the Facebook groups say and what the evidence actually supports
The supplement discussion in Long COVID communities around viral reactivation is extensive, energetic, and only partially grounded in evidence. Here is the honest version.
Lysine is the most discussed supplement for herpesvirus management. There is plausible biology behind it: lysine competes with arginine for absorption, and herpesviruses use arginine preferentially. Some studies show modest reduction in cold sore frequency. The evidence is not robust by clinical trial standards, but the risk is low and some people report meaningful benefit. Worth discussing with a clinician, particularly at doses above dietary amounts.
Monolaurin has laboratory antiviral properties. Human trial evidence is limited enough that it cannot be recommended with confidence, but it is not dangerous. Low evidence, low risk, unknown clinical benefit in this context.
NAC, CoQ10, curcumin: these are addressing oxidative stress and mitochondrial dysfunction, which are real features of Long COVID. Whether they specifically reduce herpesvirus reactivation is not established. They may support immune function generally.
Antivirals (valacyclovir, acyclovir) are the only treatments with established clinical evidence for herpesvirus management. For HSV and VZV, they demonstrably reduce outbreak severity and duration, and suppressive therapy demonstrably reduces reactivation frequency. For EBV reactivation in Long COVID, clinical trial evidence is limited and most use is based on individual clinical judgment rather than established protocols. For HHV 6, there are fewer well tolerated antiviral options.
If you are having frequent, prolonged or severe herpes simplex outbreaks since COVID, a conversation about suppressive daily antiviral therapy is a legitimate and entirely reasonable request to make of your GP.
What to do with all of this
The most useful immediate actions depend on which virus you are dealing with.
For cold sores or other HSV outbreaks: start antivirals at the first sign of prodrome, not after the blister appears. The earlier they are started, the more effectively they shorten the episode. If outbreaks are becoming more frequent, discuss suppressive therapy.
For a possible shingles rash: see a GP urgently. Antivirals within the first 72 hours make a significant difference to both duration and the risk of post herpetic neuralgia.
For suspected EBV or HHV 6 reactivation without visible symptoms: request specific reactivation markers (not just general EBV antibodies), present your symptom timeline, and ask whether antiviral treatment might be appropriate in your clinical context. You may need to advocate clearly, because EBV reactivation in Long COVID is not yet routinely assessed in most GP surgeries.
For swollen lymph nodes: get them assessed, particularly if they are persisting, growing, or accompanied by other symptoms. In the context of known viral reactivation they are almost certainly part of that picture, but it is worth confirming rather than assuming.
For everything: pacing applies here just as it does to the broader Long COVID picture. Overexertion is one of the most consistent triggers for viral reactivation. The immune system stress created by pushing past your energy limits creates exactly the environment in which latent viruses take the opportunity to become active. This is one more reason why “just push through” is not the answer.
You did not cause this. You caught a virus that temporarily gave every other virus in your body a window of opportunity. The biology is increasingly well understood. The research is moving. And the swollen lymph nodes, the cold sores, the fatigue that feels like glandular fever again: all of it makes sense in the context of an immune system that is having a very difficult time keeping everything in its place.
Why Doesn’t Everyone Experience Viral Reactivation?
Not everyone with Long COVID experiences viral reactivation, and not everyone who does will have the same virus become active.
This is one of the reasons Long COVID is so variable. Genetics, previous viral exposures, immune health, the severity of the initial infection and other underlying conditions all appear to influence which biological mechanisms become most important in each individual.
For some people, viral reactivation may be a major contributor to their symptoms. For others, autonomic dysfunction, persistent inflammation, mitochondrial dysfunction or microvascular changes may play a much larger role. Long COVID is best understood as a condition with multiple overlapping mechanisms rather than a single explanation.
Frequently asked questions about EBV reactivation
Why do old viruses reactivate after COVID?
Because SARS CoV 2 causes significant disruption to immune surveillance, particularly T cell function and natural killer cell activity, that normally keeps latent herpesviruses dormant. When that surveillance is compromised, viruses like EBV, HSV and VZV have more opportunity to reactivate. The immune disruption can persist long after the acute COVID infection resolves.
How common is EBV reactivation in Long COVID?
The original study found EBV reactivation markers in 66.7 percent of Long COVID patients compared with 10 percent of people who recovered without persistent symptoms. At least five subsequent studies have found similar patterns, with EBV reactivation particularly associated with fatigue and cognitive symptoms.
Does EBV reactivation explain Long COVID symptoms?
It likely contributes significantly for a subgroup of patients, particularly those with prominent fatigue, brain fog and lymphadenopathy. The relationship is increasingly well evidenced. However EBV reactivation is not the sole explanation for Long COVID, which involves multiple overlapping mechanisms in different patients.
Why do I have shingles when I am under 50?
Shingles in younger adults is a recognised sign of immune disruption. VZV reactivation after COVID has been documented in people well below the usual risk age. If you have or suspect shingles, see a GP urgently as antivirals within 72 hours of rash onset significantly reduce both duration and the risk of lasting nerve pain.
Are cold sores and mouth ulcers the same thing?
Not always. Cold sores caused by HSV 1 begin as blisters at the lip border or inside the mouth. Aphthous ulcers, the more common non viral mouth ulcers, appear as painful white or grey erosions without the preceding blister phase. In Long COVID, both can be more frequent. HSV mouth ulcers tend to start as fluid filled blisters before breaking down; aphthous ulcers typically appear as erosions directly. Both can be triggered by immune stress.
What do swollen lymph nodes after COVID mean?
Lymph nodes enlarge when the immune system is actively processing an infection or reactivation. Tender, soft, mobile lymph nodes in the neck in the context of known or suspected EBV or HHV 6 reactivation are consistent with immune activation rather than something sinister. Hard, rapidly growing, non tender nodes or those accompanied by significant night sweats or weight loss warrant prompt clinical assessment.
Am I contagious during EBV reactivation?
In most everyday situations, no. EBV during reactivation produces much lower salivary viral levels than primary infection. Avoiding sharing drinks, cutlery or close saliva contact during symptomatic periods is a sufficient precaution. You are not a contagion risk to colleagues, children or most family members through normal interaction.
Am I contagious during a cold sore?
Yes, during active outbreaks and during the prodrome stage before the blister appears. Direct contact with the lesion or the area around it can transmit the virus. Outside of active outbreaks, asymptomatic shedding can occasionally occur, though at much lower rates. Avoid touching the area and then touching your eyes or another person.
How do I read my EBV blood test results?
IgG positive means you have had EBV at some point. Almost all adults will be positive. IgM positive suggests recent or reactivated infection. EBV early antigen (EA D IgG) elevated is the most specific marker for reactivation and the one most relevant to Long COVID. Results need clinical context: ask your GP to interpret them alongside your symptoms rather than in isolation.
Do antivirals help with EBV reactivation in Long COVID?
For HSV and VZV, antivirals like valacyclovir demonstrably reduce outbreak severity and frequency. For EBV specifically in Long COVID, clinical trial evidence is limited. Most use is based on individual clinical judgment and some case series showing benefit. It is a legitimate conversation to have with your clinician, particularly if EBV reactivation markers are elevated alongside symptoms.
What about supplements like lysine and monolaurin?
Lysine has modest evidence for reducing cold sore frequency in some people. Monolaurin has laboratory antiviral properties but limited human trial evidence. Neither is dangerous at appropriate doses but neither has the evidence base of clinical antivirals. The biological rationale for lysine is more convincing than for most supplements in this space. Discuss with a clinician before starting.
Can viral reactivation trigger autoimmune problems?
Research suggests it can contribute. HHV 6 reactivation in Long COVID has been specifically associated with autoimmune reactions against myelin and tight junction proteins. EBV is a known trigger for autoimmune conditions including lupus and multiple sclerosis in susceptible individuals. Whether reactivation in Long COVID is triggering autoimmunity in some patients is an active research area.
Will viral reactivation keep happening indefinitely?
Frequency tends to track with overall immune stability. As Long COVID improves and the immune disruption that drove reactivation settles, episodes typically become less frequent. Consistent pacing to avoid post exertional immune stress, protected sleep, and directly treating active outbreaks rather than ignoring them are the most consistently useful approaches to reducing frequency over time.
Can I prevent viral reactivation if I have Long COVID?
There is currently no guaranteed way to prevent viral reactivation in Long COVID, but there are several steps that may help reduce the risk by supporting your immune system and avoiding known triggers.
One of the most important strategies is pacing. Overexertion can place additional stress on the immune system, and many people notice that cold sores, shingles or other viral symptoms appear after a significant physical or cognitive crash. Staying within your energy limits may help reduce these episodes.
Protecting your sleep is equally important. Poor-quality or insufficient sleep can impair immune function and increase susceptibility to viral reactivation. Managing stress, eating a balanced diet, treating nutritional deficiencies where present, and following your healthcare professional’s advice for underlying conditions may also support overall immune resilience.
If you experience frequent herpes simplex outbreaks or recurrent shingles, speak to your GP or specialist. Some people benefit from suppressive antiviral therapy, such as valaciclovir or aciclovir, although this is usually considered on an individual basis. At present, there is limited evidence that antiviral treatment prevents EBV reactivation in Long COVID, and research is ongoing
While no single strategy can eliminate the risk, maintaining the best possible overall health and avoiding repeated immune stress appears to be the most practical approach based on current evidence.
This article is for general information and education. It does not replace personalised medical advice. If you are experiencing frequent viral outbreaks, possible shingles, or swollen lymph nodes after COVID, please speak with your GP or a clinician familiar with Long COVID.
Sources and further reading
EBV and Long COVID EBV reactivation in 66.7% of Long COVID patients, original Pathogens study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233978/ EBV reactivation linked to fatigue and cognitive symptoms in Long COVID, Health Rising overview: https://www.healthrising.org/blog/2023/05/03/epstein-barr-virus-reactivation-fatigue-brainfog-long-covid/ EBV, gut brain axis and neurological symptoms in Long COVID, Molecular Psychiatry 2023: https://www.nature.com/articles/s41380-023-02161-5
HHV 6 and the wider herpesvirus picture HHV 6 reactivation, autoimmunity and Long COVID, Journal of Medical Virology 2024: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.29864 Persistent infection, EBV, HHV 6 and autoimmunity in Long COVID, PMC review: https://pmc.ncbi.nlm.nih.gov/articles/PMC9967513/ Viral suspects in Long COVID, ScienceDaily December 2025: https://www.sciencedaily.com/releases/2025/12/251214100911.htm
Bateman Horne Center on herpesvirus dysregulation: https://batemanhornecenter.org/herpes-virus-dysregulation-in-long-covid/ ENDOFFILE
About This EBV Reactivation and Long COVID Guide
This guide combines current research on viral reactivation with lived experience of Long COVID to explain how Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella zoster virus (shingles), HHV-6 and other latent viruses may become active after COVID-19. It aims to explain the evidence clearly without overstating what is known, recognising that viral reactivation is one possible contributor to Long COVID rather than a single explanation for everyone. As research continues to evolve, this article is reviewed and updated when important new findings become available. It is intended for educational purposes and should not replace personalised medical advice from your GP or healthcare professional.
One thought on “Viral Reactivation Long COVID: EBV, Herpes and Shingles”